Deploys quantitative strategies across global equity and macro markets using proprietary data science, statistical arbitrage and high-frequency signal generation. Vectors Research Management targets absolute returns with multi-strategy hedge funds and separately managed accounts, allocating capital to long/short equities, event-driven trades and systematic macro overlays. Clients include institutional allocators and family offices seeking diversified, model-driven exposure and risk-managed alpha extraction.
Deploys quantitative strategies across global equity and macro markets using proprietary data science, statistical arbitrage and high-frequency signal generation. Vectors Research Management targets absolute returns with multi-strategy hedge funds and separately managed accounts, allocating capital to long/short equities, event-driven trades and systematic macro overlays. Clients include institutional allocators and family offices seeking diversified, model-driven exposure and risk-managed alpha extraction.
Operates a quantitatively driven, multi-strategy hedge fund model emphasizing absolute return through statistical arbitrage, high‑frequency signals and systematic macro overlays. Capital deployment blends long/short equity, event‑driven and macro exposures with dynamic risk parity and volatility-targeting to preserve capital across cycles. Underwriting prioritizes signal validation, capacity-aware trades and low correlation sources; portfolio construction favors diversified, model-led bets over single-name concentration, positioning the firm as a turnkey, institutional-grade alpha generator.
Operates a quantitatively driven, multi-strategy hedge fund model emphasizing absolute return through statistical arbitrage, high‑frequency signals and systematic macro overlays. Capital deployment blends long/short equity, event‑driven and macro exposures with dynamic risk parity and volatility-targeting to preserve capital across cycles. Underwriting prioritizes signal validation, capacity-aware trades and low correlation sources; portfolio construction favors diversified, model-led bets over single-name concentration, positioning the firm as a turnkey, institutional-grade alpha generator.
| Trades 5950 | Longs Won 3149/5950 52% | Profit Factor 4.2 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $200,740.69 |
| Average Win $71,768.78 | Best Trade (Sep 01) $5.97M | Sharpe Ratio -55.36 |
| Average Loss -$19,211.34 | Worst Trade (Mar 30) -$3.74M | Z-Score -16.24 (100%) |
| Commissions $0 | Avg. Trade Length 1y 11m 3w | Expectancy $28,939.32 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 20,000 | 18,000 | 16,000 | 14,000 | 12,000 | 10,000 | 8,000 | 6,000 | 4,000 | 2,000 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 42,596 | $5.16M | $13.16M | - | $7.99M | 154.8% | -7.354% |
ABBV AbbVie Inc. | 1,505 | $149,877.88 | $377,664.7 | - | $227,786.82 | 151.98% | -2.513% |
ABT Abbott Laboratories | 14,565 | $1.74M | $1.54M | - | -$198,662.24 | -11.43% | +0.085% |
ADM Archer-Daniels-Midland Co | 3,223 | $234,280 | $255,487.21 | - | $21,207.21 | 9.05% | -1.662% |
AEP American Electric Power Company, Inc. | 21,279 | $2M | $2.72M | - | $717,774.18 | 35.84% | +0.055% |
AIQ Global X Artificial Intelligence & Technology ETF | 8,970 | $418,629.93 | $528,243.3 | - | $109,613.37 | 26.18% | +0.341% |
AMAT Applied Materials, Inc. | 850 | $614,555 | $431,519.51 | - | -$183,035.49 | -29.78% | +1.176% |
AMD Advanced Micro Devices, Inc. | 11,619 | $2.12M | $5.53M | - | $3.41M | 160.87% | -1.904% |
AMP Ameriprise Financial, Inc. | 2,480 | $321,219.5 | $1.35M | - | $1.03M | 321.42% | +0.253% |
AMZN Amazon.com Inc | 2,094 | $440,778.7 | $568,688.5 | - | $127,909.8 | 29.02% | +15.321% |
AVGO Broadcom Inc. | 9,024 | $2.78M | $3.51M | - | $735,912.37 | 26.5% | +0.371% |
AXP American Express Company | 5,340 | $660,166.6 | $1.8M | - | $1.14M | 171.99% | -0.376% |
BAC Bank of America Corporation | 55,581 | $2.3M | $3.44M | - | $1.14M | 49.54% | +0.356% |
BIL SPDR Bloomberg 1-3 Month T-Bill ETF | 2,266 | $207,656 | $207,746.88 | - | $90.88 | 0.04% | +0.033% |
| BKT BKT | 35,076 | $432,794.04 | $432,794.04 | - | - | - | 0.0 |
BMY Bristol-Myers Squibb Company | 13,000 | $680,652.66 | $849,030 | - | $168,377.34 | 24.74% | +0.694% |
BND Vanguard Total Bond Market Index Fund | 103,135 | $7.43M | $7.45M | - | $20,368.52 | 0.27% | -0.262% |
BNY BlackRock New York Municipal Income Trust | 14,278 | $1.6M | $2.23M | - | $631,855.67 | 39.49% | +0.16% |
BSV Vanguard Short-Term Bond ETF | 8,911 | $697,841.88 | $691,315.38 | - | -$6,526.5 | -0.94% | -0.077% |
BSX Boston Scientific Corporation | 13,103 | $926,868.71 | $612,303.19 | - | -$314,565.52 | -33.94% | +1.587% |